0
Arbutus Biopharma Corporation Banner Image

Arbutus Biopharma Corporation has reached its limit for free report views

Work for Arbutus Biopharma Corporation? Upgrade Your Profile and unlock all your annual reports.

Arbutus Biopharma Corporation

  • Ticker ABUS
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Arbutus Biopharma Corporation Logo Image
  • 51-200 Employees
  • Based in Warminster, Pennsylvania
Arbutus Biopharma Corporation is a publicly-traded (NASDAQ: ABUS) biopharmaceutical company dedicated to discovering,developing and commercializing a cure for people with chronic hepatitis B virus ("HBV") infection. They are advancing multiple drug product candidates that may be combined into a potentially curative regimen for chronic HBV infection. Arbutus has also initiated a drug discoveryMore and development effort for treating coronaviruses (including COVID-19).
Arbutus Biopharma Corporation

Most Recent Annual Report

Arbutus Biopharma Corporation MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Arbutus Biopharma Corporation has reached its limit for free report views.

Older/Archived Annual Reports